Susanna Cyriac

Papers

Total Citations

H-Index

About

Susanna Cyriac is a distinguished oncologist whose research focuses on optimizing treatment strategies for muscle-invasive bladder carcinoma, with a particular emphasis on neoadjuvant chemotherapy and pathologic response prediction. Her most cited work, "Predictors of Complete Pathologic Response (pT0) to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma" (2015, 61 citations), represents a pivotal contribution to urologic oncology by identifying key clinical and pathological factors that predict which patients achieve a complete pathologic response—a critical endpoint associated with improved survival outcomes. This study has guided clinicians in personalizing treatment decisions, sparing patients unnecessary toxicity while maximizing therapeutic benefit. Cyriac’s research bridges the gap between chemotherapy efficacy and surgical outcomes, offering actionable insights for multidisciplinary care teams. Her work has been instrumental in advancing the paradigm of bladder cancer management, where achieving pT0 status is a benchmark for treatment success. With over 60 citations, this paper remains a cornerstone for ongoing investigations into biomarker-driven approaches and novel therapeutic combinations. Cyriac’s contributions underscore her commitment to evidence-based oncology, making her a respected voice in the fight against genitourinary malignancies.